Quidel

Quidel Operating Cash Flow

The Operating Cash Flow of Quidel (QDEL) as of Nov 5, 2026 is 105.20 M USD. In the previous year, Operating Cash Flow was 83.00 M USD — a change of 26.75% (higher).

Operating Cash Flow

105.20 MUSD

YoY

26.75%

Last updated:

Operating Cash Flow of Quidel is 2025 105.20 M USD. Operating Cash Flow of Quidel was 2024 83.00 M USD. It decreases by 26.75% higher compared to the previous year.

The Quidel Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2018
136.35 M USD
Jan 1, 2019
134.49 M USD
Jan 1, 2020
629.76 M USD
Jan 1, 2021
805.87 M USD
Jan 1, 2022
885.30 M USD
Jan 1, 2023
280.20 M USD
Jan 1, 2024
83.00 M USD
Jan 1, 2025
105.20 M USD
The Quidel Operating Cash Flow history
YEAROperating Cash FlowYoY
105.20 MUSD+26.75%
83.00 MUSD-70.38%
280.20 MUSD-68.35%
885.30 MUSD+9.86%
805.87 MUSD+27.96%
629.76 MUSD+368.28%
134.49 MUSD-1.36%
136.35 MUSD+392.06%
27.71 MUSD+134.52%
11.82 MUSD-67.46%
36.31 MUSD+1.75%
35.69 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quidel Stock analysis

What does Quidel do? Quidel Corporation is a US-based company specializing in the production of rapid tests for medical diagnostics. It was founded in 1979 and is headquartered in San Diego, California. Since 1991, it has been listed on the NASDAQ stock exchange. Quidel initially started as Diagnostic Reagents Laboratory (DRL) and focused on manufacturing diagnostic products for the veterinary sector. In 1990, it was renamed Quidel Corporation and expanded its operations into human diagnostics. The company's business model revolves around the development and production of immunological rapid tests that can quickly and easily diagnose infectious diseases and other health problems. Quidel focuses on creating high-quality, accurate, and cost-effective test procedures that can be used by healthcare professionals or even laypersons at home. One of Quidel's core competencies is bringing to market rapid tests that are easy to perform and provide immediate results without the need to send samples to a laboratory. The company offers a wide range of rapid tests for diagnosing various diseases. These include tests for infectious diseases such as influenza, streptococcus, Lyme disease, and chlamydia, as well as tests for pregnancy, drug abuse, and cardiovascular diseases. The tests are available as single tests or panel tests that can diagnose multiple diseases simultaneously. Quidel operates in four business segments: Molecular Diagnostics, Point-of-Care Diagnostics, Immunoassays, and Specialized Diagnostic Solutions. The Molecular Diagnostics segment focuses on developing molecular diagnostic tests and instruments for laboratory use. The Point-of-Care Diagnostics segment develops and produces rapid tests for use in medical practices and hospitals. The Immunoassays segment specializes in reagent-based tests for the quantitative analysis of biomolecules. The Specialized Diagnostic Solutions segment includes specialized diagnostic products, such as test systems for monitoring antibiotic therapies. In conclusion, Quidel Corporation specializes in the development and production of rapid tests for medical diagnostics. The company offers a wide range of high-quality, accurate, and cost-effective test procedures for diagnosing infectious diseases, pregnancy, drug abuse, and cardiovascular diseases. Quidel has gained a significant market share in the diagnostics field through its rapid tests and diverse range of test panels for various conditions, and it is known for its innovative products. Quidel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Quidel stock

Operating Cash Flow of Quidel is 105.20 M USD in 2025.

Operating Cash Flow of Quidel changed from 83.00 M USD to 105.20 M USD, representing a 26.75% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow Quidel since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's Quidel historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Quidel

All Key Metrics — Quidel